We first exploited a mouse model based on Cre-Lox inactivation of Apc in hepatocytes (Apc∆hep) that recapitulates both hepatocellular carcinoma and hepatoblastoma with aberrant β-catenin activation [22, 40, 41]. This evidence concerns the gene APC and hepatoblastoma.